Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Avraham Gabay (Chief Financial Officer): Sale of 20,000 shares, $90.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Avraham Gabay, Chief Financial Officer | Sale | 20,000 | $90.2K |
| Oct 2, 2026 | Joshua Hexter, COO & CBO | Sale | 30,000 | $135.3K |
| Sep 25, 2026 | Nadav Kidron, President and CEO | Grant/Award | 349,497 | n/a |
| Sep 25, 2026 | Joshua Hexter, COO & CBO | Grant/Award | 75,455 | n/a |
| Sep 25, 2026 | Miriam Kidron, Chief Scientific Officer | Grant/Award | 208,125 | n/a |
| Sep 25, 2026 | Avraham Gabay, Chief Financial Officer | Grant/Award | 209,291 | n/a |
| Jul 2, 2026 | Joshua Hexter, COO & CBO | Sale | 137,000 | $611.4K |
| Jul 2, 2026 | Avraham Gabay, Chief Financial Officer | Sale | 73,360 | $330.7K |
| Mar 31, 2026 | Nadav Kidron, President and CEO | Tax Withholding | 44,818 | $148.3K |
| Mar 31, 2026 | Miriam Kidron, Chief Scientific Officer | Tax Withholding | 435,084 | $1.44M |